Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Three Emerging Trends For China’s Pharmaceutical Foreign Trade

This article was originally published in PharmAsia News

Executive Summary

With the global economic slowdown, China's pharmaceutical foreign trade is likely to face its most difficult year yet since the beginning of the new century. In 2009, three development trends are emerging: (1) growth is expected to continue, with China maintaining its advantage and global market share in drug raw materials, especially antibiotics, vitamins, antipyretic analgesics and amino acids; (2) medical imports and exports will balance out health care reform resulting in increased domestic demand that will increase import volumes for major medical devices, technology, Western medicine and biomedicine, with high-end medical device import growth expected to hit double digits; and (3) many barriers will be encountered due to the rising yuan and intensifying trade war against China-made products. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts